Stephen Hurst
Equibles does not estimate personal net worth.
Get an email with a short summary when Definium Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DFTX alertsAbout Stephen Hurst
Stephen Hurst is recorded as CEO at Definium Therapeutics, Inc. (DFTX). The proxy statement of Definium Therapeutics, Inc. reports total compensation of $1,059,315 for Stephen Hurst in fiscal 2021, including a base salary of $118,333. Definium Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Definium Therapeutics, Inc. includes Dr. Roger Crystal (CEO), Dr. Suzanne Bruhn (CEO), JR Rahn (CEO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Definium Therapeutics, Inc.
- Dr. Roger Crystal CEO
- Dr. Suzanne Bruhn CEO
- JR Rahn CEO
- Robert Barrow CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
- Andreas Krebs Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Definium Therapeutics, Inc. (DFTX) | Former Co-Chief Executive Officer | $118,333 | $1,059,315 |
Recent activity
No call appearances or filed executive changes recorded yet.